The Beauty Health Company

NasdaqCM:SKIN Stock Report

Market Cap: US$437.0m

Beauty Health Future Growth

Future criteria checks 4/6

Beauty Health is forecast to grow earnings and revenue by 122.9% and 6.5% per annum respectively. EPS is expected to grow by 124.9% per annum. Return on equity is forecast to be 46% in 3 years.

Key information

122.9%

Earnings growth rate

124.9%

EPS growth rate

Personal Products earnings growth23.6%
Revenue growth rate6.5%
Future return on equity46.0%
Analyst coverage

Good

Last updated18 Mar 2024

Recent future growth updates

Recent updates

The Beauty Health Company (NASDAQ:SKIN) Stock Rockets 31% But Many Are Still Ignoring The Company

Feb 16
The Beauty Health Company (NASDAQ:SKIN) Stock Rockets 31% But Many Are Still Ignoring The Company

The Beauty Health Company's (NASDAQ:SKIN) Share Price Matching Investor Opinion

Jun 19
The Beauty Health Company's (NASDAQ:SKIN) Share Price Matching Investor Opinion

Is The Beauty Health Company (NASDAQ:SKIN) Trading At A 39% Discount?

May 28
Is The Beauty Health Company (NASDAQ:SKIN) Trading At A 39% Discount?

At US$13.26, Is The Beauty Health Company (NASDAQ:SKIN) Worth Looking At Closely?

Apr 04
At US$13.26, Is The Beauty Health Company (NASDAQ:SKIN) Worth Looking At Closely?

Beauty Health's (NASDAQ:SKIN) Earnings Are Of Questionable Quality

Mar 08
Beauty Health's (NASDAQ:SKIN) Earnings Are Of Questionable Quality

What Is The Beauty Health Company's (NASDAQ:SKIN) Share Price Doing?

Jan 01
What Is The Beauty Health Company's (NASDAQ:SKIN) Share Price Doing?

An Intrinsic Calculation For The Beauty Health Company (NASDAQ:SKIN) Suggests It's 24% Undervalued

Dec 05
An Intrinsic Calculation For The Beauty Health Company (NASDAQ:SKIN) Suggests It's 24% Undervalued

The Beauty Health Company: A Compelling Mid To Long-Term Growth Story

Oct 12

Beauty-Health Company announces $200M buyback program

Sep 27

The Beauty Health Q2 2022 Earnings Preview

Aug 08

The Beauty Health Company: Not Looking The Best

Jul 30

Beauty Health: Skincare Today And Alpha Tomorrow

May 13

Results: The Beauty Health Company Exceeded Expectations And The Consensus Has Updated Its Estimates

May 12
Results: The Beauty Health Company Exceeded Expectations And The Consensus Has Updated Its Estimates

Calculating The Intrinsic Value Of The Beauty Health Company (NASDAQ:SKIN)

Apr 22
Calculating The Intrinsic Value Of The Beauty Health Company (NASDAQ:SKIN)

Beauty Health: Growth Over The Next Half-Decade Will Be Material

Nov 29

The Beauty Health Company's (NASDAQ:SKIN) Intrinsic Value Is Potentially 59% Above Its Share Price

Oct 11
The Beauty Health Company's (NASDAQ:SKIN) Intrinsic Value Is Potentially 59% Above Its Share Price

Beauty Health: Q2 Results Support The Bull Thesis

Aug 28

A "category creator," Canaccord initiates Beauty Health as a buy; shares up 3%

Jun 15

Earnings and Revenue Growth Forecasts

NasdaqCM:SKIN - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20264963244503
12/31/202545211416713
12/31/2024401-20162111
12/31/2023398-100-1022N/A
9/30/2023399-84-1122N/A
6/30/2023391-10-63-28N/A
3/31/2023377-7-118-81N/A
12/31/202236644-125-107N/A
9/30/202234620-123-98N/A
6/30/2022325-195-85-66N/A
3/31/2022288-340-86-68N/A
12/31/2021260-379-44-28N/A
9/30/2021220-365-40-32N/A
6/30/2021186-152-40-33N/A
3/31/2021134-23N/AN/AN/A
12/31/2020119-29-16-12N/A
9/30/2020131-19-12-3N/A
12/31/2019167-2-92N/A
12/31/2018112-91-9-1N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: SKIN is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.3%).

Earnings vs Market: SKIN is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: SKIN is expected to become profitable in the next 3 years.

Revenue vs Market: SKIN's revenue (6.5% per year) is forecast to grow slower than the US market (8% per year).

High Growth Revenue: SKIN's revenue (6.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: SKIN's Return on Equity is forecast to be very high in 3 years time (46%).


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.